Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval - Quiz - MDSpire

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

  • By

  • Ayalew Tefferi

  • Animesh Pardanani

  • March 18, 2024

  • 0 min

Share

Original Source(s)

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

  • by Ayalew Tefferi, Animesh Pardanani

  • March 18, 2024

Related Content

Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study

Novel PTRH2::ALK Fusion in ALK-positive Histiocytosis Presenting as a Liver Abscess in an Infant: A Case Study

Increasing Length of the Babesia Season in New England in the Climate Change Era